로딩 중…
지수 로딩 중…
인바이오
352940· KOSDAQ· Materials· Materials
₩2,005+0.55%
2026-08-04
Financials
Valuation Metrics
인바이오's Market Cap is ₩218B. At end of 2025 it was ₩247B. Ranked #2262 of 2,436 in KR market (top 93%), #1489 of 1,649 on KOSDAQ (top 90%), #274 of 294 in Materials (top 93%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 21.79B KRW | KR#2,262/2,436 Sec#274/294 |
| Revenue | 34.26B KRW | KR#1,975/2,436 Sec#269/294 |
| Net Income | 797.6M KRW | KR#1,440/2,436 Sec#184/294 |
| Total Assets | 74.15B KRW | KR#1,951/2,436 Sec#265/294 |
| Net Assets | 44.56B KRW | KR#1,952/2,436 Sec#258/294 |
| Employees | 147 | KR#1,336/2,436 Sec#163/294 |
| Value | ||
| P/E | 27.32x | KR#1,220/2,436 Sec#162/294 |
| P/B | 0.49x | KR#782/2,436 Sec#155/294 |
| P/S | 0.64x | KR#1,091/2,436 Sec#188/294 |
| EV/EBITDA | 45.02x | KR#1,316/2,436 Sec#164/294 |
| FCF Yield | 10.40% | KR#611/2,436 Sec#70/294 |
| Profitability | ||
| ROE | 1.79% | KR#1,348/2,436 Sec#159/294 |
| ROA | 1.08% | KR#1,304/2,436 Sec#159/294 |
| Op. Margin | 2.60% | KR#1,278/2,436 Sec#149/294 |
| Revenue Growth | 2.24% | KR#1,302/2,436 Sec#168/294 |
| Earnings Growth | -8.68% | KR#973/2,436 Sec#119/294 |
| Financial Health | ||
| Debt Ratio | 166.39% | KR#1,391/2,436 Sec#184/294 |
| Total Debt | 18.42B KRW | KR#1,389/2,436 Sec#208/294 |
| FCF | 2.27B KRW | KR#1,062/2,436 Sec#127/294 |
| Cash | 34.3M KRW | KR#2,397/2,436 Sec#289/294 |
| Current Ratio | 2.09x | KR#893/2,436 Sec#92/294 |
| Net Debt/EBITDA | 20.60x | KR#1,432/2,436 Sec#168/294 |
| Performance | ||
| 1Y Return | -15.40% | KR#1,118/2,436 Sec#139/294 |
| 1M Return | -0.25% | KR#906/2,436 Sec#110/294 |
| From 52W High | -22.44% | KR#218/2,436 Sec#30/294 |
| 1Y MDD | -29.02% | KR#183/2,436 Sec#37/294 |
| Trading | ||
| Volume | 16,158 shares | KR#1,952/2,436 Sec#224/294 |
| Foreign Own. | 1.19% | KR—/2,436 Sec—/294 |
| Per Share | ||
| EPS | 73 KRW | KR#1,413/2,436 Sec#173/294 |
| BPS | 4,101 KRW | KR#1,604/2,436 Sec#217/294 |
Company Info
동사는 1997년 농약 제조 및 판매를 목적으로 설립된 후 2020년 코스닥시장에서 상장됨. 살균, 살충, 제초제 등 작물 보호제와 비료를 농협경제지주 및 지역별 도소매상을 통해 판매하고, 다기능 살균살충제 및 친환경 작물보호제를 생산함. 최근 10년간 174품목 개발 등록과 노동력 절감 효과가 있는 합제 및 고부가가치 제품 개발에 집중하며, 세계 최초 바이러스 치료제 등록 신청 등 지속적인 연구개발을 추진하고 있음. 인바이오는 1997년에 설립되었으며 경기도 군포시에 본사를 두고 있습니다.